These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 1334770)
1. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids. Miaskowski C; Levine JD Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770 [TBL] [Abstract][Full Text] [Related]
2. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Miaskowski C; Sutters KA; Taiwo YO; Levine JD Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544 [TBL] [Abstract][Full Text] [Related]
3. Antinociception produced by receptor selective opioids. Modulation of supraspinal antinociceptive effects by spinal opioids. Miaskowski C; Taiwo YO; Levine JD Brain Res; 1993 Apr; 608(1):87-94. PubMed ID: 8388314 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of spinal opioid analgesia by supraspinal administration of selective opioid antagonists. Miaskowski C; Levine JD Brain Res; 1992 Nov; 596(1-2):41-5. PubMed ID: 1361418 [TBL] [Abstract][Full Text] [Related]
5. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat. Miaskowski C; Taiwo YO; Levine JD Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of antinociceptive and motor effects of supraspinal opioid agonists in the rat. Franck LS; Miaskowski C; Putris J; Levine JD Brain Res; 1991 Nov; 563(1-2):123-6. PubMed ID: 1664771 [TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat. Miaskowski C; Sutters KA; Taiwo YO; Levine JD Brain Res; 1991 Jul; 553(1):105-9. PubMed ID: 1933267 [TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related]
10. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice. DeLander GE; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055 [TBL] [Abstract][Full Text] [Related]
11. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat. Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088 [TBL] [Abstract][Full Text] [Related]
12. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists. Murray CW; Cowan A J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats. Przewłocka B; Dziedzicka M; Lasoń W; Przewłocki R Life Sci; 1992; 50(1):45-54. PubMed ID: 1345879 [TBL] [Abstract][Full Text] [Related]
14. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids. Sutters KA; Miaskowski C; Taiwo YO; Levine JD Brain Res; 1990 Oct; 530(2):290-4. PubMed ID: 1979930 [TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
16. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat. Danzebrink RM; Green SA; Gebhart GF Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489 [TBL] [Abstract][Full Text] [Related]
17. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related]
18. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone. Hammond DL; Stewart PE; Littell L J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504 [TBL] [Abstract][Full Text] [Related]
19. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]